P. Sánchez Rovira

Clinical relevance associated to the analysis of circulating tumour cells in patients with solid tumours

J. A. Lorente Acosta, Juan Carlos Álvarez Merino, Marina Serrano Fernández, 2009, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

A retrospective, multicenter study of the efficacy of lapatinib plus trastuzumab in HER2-positive metastatic breast cancer patients previously treated with trastuzumab, lapatinib, or both: the Trastyvere study

J. Brunet, A. Guerrero-Zotano, A. Llombart-Cussac, 2020, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study.

P. Albers, M. Moore, I. Bodrogi, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Triplet Chemotherapy Combination With Gemcitabine, Cisplatin and Ifosfamide in Patients With Advanced Non-Small-Cell Lung Cancer: Phase II Study

P. Sánchez Rovira, Nicolás Mohedano Mohedano, Ana Lozano Barriuso, 2003, American journal of clinical oncology.

Clinical and Sociodemographic Determinants of Adherence to World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) Recommendations in Breast Cancer Survivors—Health-EpiGEICAM Study

A. Guerrero-Zotano, S. González, M. Pollán, 2022, Cancers.

Preventive treatments for breast cancer: recent developments

A. Ruíz, R. Andrés, A. Barnadas, 2014, Clinical and Translational Oncology.

Pan-European Expert Meeting on the Use of Metronomic Chemotherapy in Advanced Breast Cancer Patients: The PENELOPE Project

V. Torri, X. Pivot, G. Bocci, 2018, Advances in Therapy.

Polymorphisms within Autophagy-Related Genes as Susceptibility Biomarkers for Multiple Myeloma: A Meta-Analysis of Three Large Cohorts and Functional Characterization

Abhishek Kumar, E. Ziv, N. Camp, 2023, International journal of molecular sciences.

Challenging Endocrine Sensitivity of Hormone Receptor-Positive/HER2-Negative Advanced Breast Cancer with the Combination of Eribulin and Endocrine Therapy: The REVERT Study

A. Llombart-Cussac, J. Cortés, A. Martínez-Bueno, 2022, Cancers.

Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study.

I. Bodrogi, P. Conte, H. von der Maase, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cross-sectional and longitudinal associations of adherence to WCRF/AICR cancer prevention recommendations with health-related quality of life in breast cancer survivors. Health-EpiGEICAM study.

A. Guerrero-Zotano, M. Pollán, J. García-Saenz, 2024, The journal of nutrition, health & aging.

Assessment of Untargeted Metabolomics by Hydrophilic Interaction Liquid Chromatography−Mass Spectrometry to Define Breast Cancer Liquid Biopsy-Based Biomarkers in Plasma Samples

P. Sánchez Rovira, Francisca Vicente, A. Cano Jiménez, 2024, International journal of molecular sciences.